SC Filed 2021-12-07 Event — SEC 0000902664-21-005176 →

Caligan Partners LP → Liquidia Corp LQDA

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 15/100 · Filer 90d Win Rate: 100% · Hist. 90d Edge: +65.6%

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Short interest building (+36.9% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

12 transactions

0 buys · 5 sales · 7 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.98

17,303,701 shares short · +36.9% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $17.25M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-12	JEFFS ROGER	director, officer	Sale	32,744	$28.48	$933K
2026-10-12	Boyle Dana	officer	Sale	5,892	$28.48	$168K
2026-10-12	Adair Jason	officer	Sale	7,301	$28.48	$208K
2026-10-09	JEFFS ROGER	director, officer	Option exercise	13,833	—	—
2026-10-09	JEFFS ROGER	director, officer	Option exercise	14,333	—	—
2026-10-09	Boyle Dana	officer	Option exercise	3,178	—	—
2026-10-09	Adair Jason	officer	Option exercise	3,906	—	—
2026-10-09	Adair Jason	officer	Option exercise	2,474	—	—
2026-10-09	Adair Jason	officer	Option exercise	3,868	—	—
2026-07-13	Boyle Dana	officer	Sale	641	$71.39	$46K
2026-07-13	Boyle Dana	officer	Sale	8,361	$71.52	$598K
2026-07-10	Boyle Dana	officer	Option exercise	3,179	—	—

Other 13D/G Filings on Liquidia Corp

Filed	Form	Filer	Stake	Shares
2022-01-05	SC	New Enterprise Associates 12, Limited Partnership	—	—	view →

Other Filings by Caligan Partners LP

Filed	Form	Issuer	Stake	Shares
2026-01-27	SCHEDULE	Anika Therapeutics, Inc. ANIK	9.95%	1,435,130	view →
2024-05-30	SC	Anika Therapeutics, Inc. ANIK	—	—	view →
2024-01-08	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2023-07-03	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2023-06-02	SC	EXELIXIS, INC. EXEL	—	—	view →
2022-08-05	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2020-11-16	SC	AMAG PHARMACEUTICALS, INC.	—	—	view →
2019-10-10	SC	AMAG PHARMACEUTICALS, INC.	—	—	view →
2019-09-30	SC	Knowles Corp KN	—	—	view →
2019-09-04	SC	AMAG PHARMACEUTICALS, INC.	—	—	view →
2019-05-09	SC	Knowles Corp KN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →